One study conducted in Argentina that included 155 women with breast cancer, ovarian cancer, and both, with an average age of 42 years (range: 28–81 years), showed a prevalence of 25.8% of BRCA1 and BRCA2 mutations among patients who met the criteria for hereditary ovarian cancer [51]. The gene discussed is BRCA2; the disease is breast cancer.